Key Changes Approved by Board
Director Resignation: Dr. Thomas Hoffmann (DIN: 06485949) resigned as Non-Executive and Non-Independent Director effective November 30, 2026. The resignation reason is expansion of responsibilities at Bayer AG. No other material reasons cited.
Director Appointment: Ms. Christiane Temminghoff (DIN: 11973532) appointed as Additional Director (Non-Executive and Non-Independent) effective December 1, 2026, based on Nomination and Remuneration Committee recommendations. Appointment is subject to shareholder approval.
Senior Management Resignation: Mr. Rajaram Mohan Babu Boppana (DIN: 10799293) resigned as Cluster Commercial Lead and Senior Management Personnel effective December 31, 2026, to pursue an external career opportunity. No other material reasons cited.
Director Profile Details
Ms. Christiane Temminghoff serves as Head of Countries and Enablement within Finance at Bayer's Group Headquarters in Leverkusen. She joined Bayer in 2001 and has held various strategic finance roles including CFO in Hungary (2019-2022), Chief Executive Officer and CFO for Bayer in Nordics (2022-2024), and currently leads Bayer's country cluster CFO organizations and global Managing Director Community since January 2024. She holds a degree in business administration.
Confirmation Statements
Ms. Christiane Temminghoff is not related to any existing directors as defined under Section 2(77) of Companies Act, 2013. She is not debarred from holding director office by virtue of any SEBI order or statutory authority.
Financial Impact
Financial impact not quantified in the disclosure.